Welcome to our dedicated page for Predictmedix news (Ticker: PMEDF), a resource for investors and traders seeking the latest updates and insights on Predictmedix stock.
Predictmedix Inc. (PMEDF) delivers AI-driven health screening solutions for global safety challenges. This page provides investors and stakeholders with official news updates on technological advancements, strategic partnerships, and operational developments.
Access real-time updates on AI health screening innovations, including deployments in healthcare, aviation, and government sectors. Track announcements related to Safe Entry Stations, regulatory milestones, and financial performance.
Users can expect verified updates on multispectral imaging breakthroughs, government contract awards, and expansion into new markets. All content is sourced directly from company filings and authorized communications.
Bookmark this page for streamlined access to Predictmedix's evolving role in non-invasive health monitoring technology. Check regularly for developments impacting public health infrastructure and workplace safety standards.
Predictmedix AI (CSE: PMED) (OTC: PMEDF) has announced a non-brokered private placement offering of up to 50,000,000 units at C$0.02 per unit, aiming to raise up to C$1,000,000. Each unit consists of one common share and one warrant, with each warrant allowing the purchase of one common share at C$0.05 within 24 months of closing.
The company has begun receiving commitments for the placement, according to COO Dr. Rahul Kushwah. The proceeds will be allocated to general working capital and expanding market opportunities in the U.S. for AI-powered health management solutions across enterprise and government sectors. All securities issued will have a four-month and one-day statutory hold period.
FAQ
What is the current stock price of Predictmedix (PMEDF)?
What is the market cap of Predictmedix (PMEDF)?
